Skip to main content
SpringerLink
Log in

COVID-19-related deaths not increased with ACE inhibitor or ARB use

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. polymerase chain reaction

Reference

  • Christiansen CF, et al. SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis. Thorax : 8 Dec 2020. Available from: URL: http://doi.org/10.1136/thoraxjnl-2020-215768

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

COVID-19-related deaths not increased with ACE inhibitor or ARB use. Reactions Weekly 1835, 5 (2020). https://doi.org/10.1007/s40278-020-87449-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-87449-1

Search

Navigation